PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds
PepGen is one of several companies vying to bring to market the first treatment for the rare muscle disorder myotonic dystrophy type 1, or DM1. Preliminary Phase 1 data indicate its drug candidate is competitive with others further ahead in development. The post PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds appeared first on MedCity News.
PepGen is one of several companies vying to bring to market the first treatment for the rare muscle disorder myotonic dystrophy type 1, or DM1. Preliminary Phase 1 data indicate its drug candidate is competitive with others further ahead in development.
The post PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds appeared first on MedCity News.
